Naloxone Administration in
CBRFs
The DHS Division of Quality Assurance has issued a publication, Community-Based
Residential Facility – Naloxone Administration
(P-02091), which provides guidance for the storage and administration of nasal spray Naloxone in a CBRF licensed under Wis. Stat. § 50 and Wis. Admin. Code §. DHS 83.
As stated in Executive Order 214, Public Health
Advisory, the misuse and abuse of opioids is a public health crisis. Naloxone is a medication that can reverse an opioid overdose. It can be given as an injection or as a nasal spray. Naloxone is often sold under the brand name Narcan. Information regarding the use of Naloxone is available on the Department of Health Services (DHS) “Opioids – Overdose” webpage.
If you have questions about this publication, please contact Doug Englebert, DQA Pharmacy Consultant, at Douglas.Englebert@wisconsin.gov.
|
